Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

No survival benefit to adding bevacizumab to standard first-line chemoradiation for glioblastoma

Dr Mark R. Gilbert - University of Texas MD Anderson Cancer Center, Houston, USA
No survival benefit to adding bevacizumab to standard first-line chemoradiation for glioblastoma ( Dr Mark R. Gilbert - University of Texas MD Anderson Cancer Center, Houston, USA )
2 Jun 2013

AMAROS trial: radiotherapy versus lymph node dissection in breast cancer

Dr Robert Mansel - Cardiff University, UK
AMAROS trial: radiotherapy versus lymph node dissection in breast cancer ( Dr Robert Mansel - Cardiff University, UK )
2 Jun 2013

Treatment of primary central nervous system germinoma with chemotherapy

Dr Jonathan Finlay - Children's Hospital Los Angeles, USA
Treatment of primary central nervous system germinoma with chemotherapy ( Dr Jonathan Finlay - Children's Hospital Los Angeles, USA )
29 May 2013

Treating peripheral lung tumours with SABR

Dr Suresh Senan - VU University medical center, Amsterdam, the Netherlands
Treating peripheral lung tumours with SABR ( Dr Suresh Senan - VU University medical center, Amsterdam, the Netherlands )
16 May 2013

Diagnosis and treatment in rare cases of thymoma

Dr Walter Klepetko - Vienna Medical University, Austria
Diagnosis and treatment in rare cases of thymoma ( Dr Walter Klepetko - Vienna Medical University, Austria )
16 May 2013

Treating non-small cell lung cancer with surgery versus SABR

Dr Paul Van Schil and Dr Kevin Franks
Treating non-small cell lung cancer with surgery versus SABR ( Dr Paul Van Schil and Dr Kevin Franks )
16 May 2013

Using chemo-radiotherapy without increasing toxicity

Dr Dirk De Ruysscher - Leuven University, Belgium
Using chemo-radiotherapy without increasing toxicity ( Dr Dirk De Ruysscher - Leuven University, Belgium )
15 May 2013

Early effect of PI3K-Akt-mTOR blockade on in vitro 18F-FDG uptake in HER2 breast cancer resistant to trastuzumab

Dr Yanina Dockx - University of Antwerp, Edegem, Belgium
Early effect of PI3K-Akt-mTOR blockade on in vitro 18F-FDG uptake in HER2  breast cancer resistant to trastuzumab ( Dr Yanina Dockx - University of Antwerp, Edegem, Belgium )
15 May 2013

Approaches to treatment of brain metastasis

Dr Elisabetta Munzone - European Institute of Oncology, Milan, Italy
Approaches to treatment of brain metastasis ( Dr Elisabetta Munzone - European Institute of Oncology, Milan, Italy )
23 Apr 2013

Closing the cancer divide: Implementing the diagonal approach

Dr Felicia Knaul - Harvard Medical School, Boston, USA
Closing the cancer divide: Implementing the diagonal approach ( Dr Felicia Knaul - Harvard Medical School, Boston, USA )
19 Apr 2013

Chemo-radiotherapy for bladder cancer

Prof Nick James - University of Birmingham, UK
Chemo-radiotherapy for bladder cancer ( Prof Nick James	 - University of Birmingham, UK )
25 Feb 2013

Pelvic radiotherapy and androgen blockade for high risk prostate cancer

Dr Abdenour Nabid - Sherbrooke University, Quebec, Canada
Pelvic radiotherapy and androgen blockade for high risk prostate cancer ( Dr Abdenour Nabid - Sherbrooke University, Quebec, Canada )
25 Feb 2013